Their further study extended to human HCC cell lines and discovered that SRY maintains the CSCs properties, including self-renewal, chemoresistance, and tumorigenicity, by transactivating the classic CSCs marker OCT4 and up-regulating other CSCs markers such as CD13, thereby contributing to HCC progression [26]. This evidence concerns the gene POU5F1 and hepatocellular carcinoma.